Encorafenib will be administered on a 300 mg QD schedule and binimetinib will be administered on a 4
This page covers all Encorafenib will be administered on a 300 mg QD schedule and binimetinib will be administered on a 4 drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds.
Patent intelligence
- encorafenib will be administered on a 300 mg qd schedule and binimetinib will be administered on a 4 patent landscape — aggregated cliff calendar, attackable patents, originator estates